Insider · CIK 0001856081

Virani Shafique

Reports to the SEC for 1 company · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001856081

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-16	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+18K sh	$2.22	+$40K	154,748
2024-01-16	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−18K sh	$10.93	−$197K	136,748
2024-01-16	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−18K sh	—	—	361,469
2023-12-15	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+18K sh	$2.22	+$40K	154,748
2023-12-15	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−18K sh	$9.60	−$173K	136,748
2023-12-15	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−18K sh	—	—	379,469
2023-11-15	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+18K sh	$2.22	+$40K	158,351
2023-11-15	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−18K sh	$6.51	−$117K	140,351
2023-11-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Business Officer	FTax Payment	−3,603 sh	$7.18	−$25.9K	136,748
2023-11-15	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−18K sh	—	—	397,469
2023-10-16	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+18K sh	$2.22	+$40K	158,351
2023-10-16	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−18K sh	$6.30	−$113K	140,351
2023-10-16	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−18K sh	—	—	415,469
2023-09-15	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+18K sh	$2.22	+$40K	158,351
2023-09-15	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−18K sh	$8.66	−$156K	140,351
2023-09-15	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−18K sh	—	—	433,469
2023-08-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Business Officer	FTax Payment	−3,603 sh	$9.19	−$33.1K	140,351
2023-08-15	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+18K sh	$2.22	+$40K	158,351
2023-08-15	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−18K sh	$9.25	−$167K	140,351
2023-08-15	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−18K sh	—	—	451,469
2023-07-26	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+20K sh	$2.22	+$44.4K	163,954
2023-07-26	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−20K sh	$14.41	−$288K	143,954
2023-07-26	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−20K sh	—	—	469,469
2023-07-25	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+20K sh	$2.22	+$44.4K	163,954
2023-07-25	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−20K sh	$14.30	−$286K	143,954
2023-07-25	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−20K sh	—	—	489,469
2023-07-18	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+30K sh	$2.22	+$66.6K	173,954
2023-07-18	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−30K sh	$13.74	−$412K	143,954
2023-07-18	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−30K sh	—	—	509,469
2023-07-17	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+30K sh	$2.22	+$66.6K	173,954
2023-07-17	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−30K sh	$11.72	−$352K	143,954
2023-07-17	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−30K sh	—	—	539,469
2023-06-16	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+30K sh	$2.22	+$66.6K	173,954
2023-06-16	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−30K sh	$9.41	−$282K	143,954
2023-06-16	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−30K sh	—	—	569,469
2023-06-15	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+30K sh	$2.22	+$66.6K	173,954
2023-06-15	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−30K sh	$9.67	−$290K	143,954
2023-06-15	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−30K sh	—	—	599,469
2023-06-02	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−17.9K sh	$8.93	−$160K	143,954
2023-06-01	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−25K sh	$8.58	−$215K	161,819
2023-05-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Business Officer	FTax Payment	−2,230 sh	$5.60	−$12.5K	185,102
2023-02-16	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−1,768 sh	$8.42	−$14.9K	187,332
2023-02-15	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+7,486 sh	$2.22	+$16.6K	197,332
2023-02-15	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Business Officer	SSale	−7,486 sh	$8.33	−$62.4K	189,846
2023-02-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Business Officer	FTax Payment	−746 sh	$8.44	−$6,296.24	189,100
2023-02-15	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+7,486 sh	—	—	629,469
2023-02-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Business Officer	AAward	+106K sh	—	—	182,003
2023-02-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Business Officer	AAward	+10.8K sh	—	—	192,840
2023-02-01	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Business Officer	FTax Payment	−2,994 sh	$8.55	−$25.6K	189,846
2023-02-01	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+213K sh	—	—	212,507

Recent filings

Accepted (ET)
Jan 184
Virani Shafique0001209191-24-001870
SEC(opens sec.gov)
Dec 194
Virani Shafique0001209191-23-059254
SEC(opens sec.gov)
Nov 174
Virani Shafique0001209191-23-055843
SEC(opens sec.gov)
Oct 184
Virani Shafique0001209191-23-053107
SEC(opens sec.gov)
Sep 194
Virani Shafique0001209191-23-050033
SEC(opens sec.gov)
Aug 174
Virani Shafique0001209191-23-046424
SEC(opens sec.gov)

Companies

RECURSION PHARMACEUTICALS, INC.Chief Business OfficerRXRX

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101